Bill Gates is the primary funder of the MHRA & owns major shares in both Pfizer & BioNTech – Is there any wonder the MHRA authorised the jab for use in children? BY
An investigation has revealed that the Bill & Melinda Gates Foundation are the primary funders of the UK’s Medicine & Healthcare products Regulatory Agency, and that the Foundation also owns major shares in both Pfizer and BioNTech.
The Medicine & Healthcare products Regulatory Agency (MHRA) extended the emergency authorisation of the Pfizer / BioNTech mRNA jab in the UK to allow it to be given to children between the ages of 12 – 15 on the 4th June 2021.
At the time, the Chief Executive of the MHRA, Dr June Raine said the MHRA had “carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer vaccine is safe and effective in this age group and that the benefits outweigh any risk”.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
We are left wondering if Dr June Raine and the MHRA have even read the results of the extremely short and small study. If they have then they would have seen that 86% of children in the study suffered an adverse reaction ranging from mild to extremely serious.
Just 1,127 children took part of the trial, however only 1,097 children completed the trial, with 30 of them not participating after being given the first dose of the Pfizer jab. The results do not state why the 30 children did not go on to complete the trial.
The information is publicly available and contained within an FDA fact sheet which can be viewed here (see page 25, table 5 on-wards).
There was never any doubt that the MHRA would give emergency authorisation for the Pfizer / BioNTech vaccine to be used in children when you consider that a certain Mr Bill Gates owns shares in both Pfizer and BioNTech and is the primary funder of the MHRA.